173 related articles for article (PubMed ID: 35935409)
21. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.
Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ
Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993
[TBL] [Abstract][Full Text] [Related]
23. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
[TBL] [Abstract][Full Text] [Related]
24. Self-reported reasons for discontinuation or continuation of antipsychotic medication in individuals with first-episode schizophrenia.
Stürup AE; Hjorthøj C; Jensen HD; Melau M; Davy JW; Nordentoft M; Albert N
Early Interv Psychiatry; 2023 Oct; 17(10):974-983. PubMed ID: 36693651
[TBL] [Abstract][Full Text] [Related]
25. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
[TBL] [Abstract][Full Text] [Related]
26. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
Zipursky RB; Odejayi G; Agid O; Remington G
Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
[TBL] [Abstract][Full Text] [Related]
27. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
Miller BJ
J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
[TBL] [Abstract][Full Text] [Related]
28. Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan.
Yen K; Liu CC; Lin YT; Chien YL; Hsieh MH; Liu CM; Hwang TJ; Liao WH; Hwu HG
Neuropsychiatr Dis Treat; 2022; 18():465-475. PubMed ID: 35261544
[TBL] [Abstract][Full Text] [Related]
29. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
[TBL] [Abstract][Full Text] [Related]
30. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
31. Medication strategies in first episode psychosis patients: A survey among psychiatrists.
Kikkert MJ; Veling W; de Haan L; Begemann MJH; de Koning M; ; Sommer IE
Early Interv Psychiatry; 2022 Feb; 16(2):139-146. PubMed ID: 33754470
[TBL] [Abstract][Full Text] [Related]
32. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study.
Guo X; Zhai J; Liu Z; Fang M; Wang B; Wang C; Hu B; Sun X; Lv L; Lu Z; Ma C; He X; Guo T; Xie S; Wu R; Xue Z; Chen J; Twamley EW; Jin H; Zhao J
Arch Gen Psychiatry; 2010 Sep; 67(9):895-904. PubMed ID: 20819983
[TBL] [Abstract][Full Text] [Related]
33. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
34. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
[TBL] [Abstract][Full Text] [Related]
35. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.
Cheng Z; Yuan Y; Han X; Yang L; Zeng X; Yang F; Lu Z; Wang C; Deng H; Zhao J; Xiang YT; Correll CU; Yu X
Psychiatry Res; 2019 Mar; 273():631-640. PubMed ID: 30735922
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
[TBL] [Abstract][Full Text] [Related]
37. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
Constantine RJ; Andel R; McPherson M; Tandon R
Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review of the Need for Guideline Recommendations; Slow Tapering vs. Maintenance Dose in Long-Term Antipsychotic Treatment: 2022.
Potla S; Al Qabandi Y; Nandula SA; Boddepalli CS; Gutlapalli SD; Lavu VK; Abdelwahab Mohamed Abdelwahab R; Huang R; Hamid P
Cureus; 2023 Feb; 15(2):e34746. PubMed ID: 36777974
[TBL] [Abstract][Full Text] [Related]
39. Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives.
Ascher-Svanum H; Nyhuis AW; Stauffer V; Kinon BJ; Faries DE; Phillips GA; Schuh K; Awad AG; Keefe R; Naber D
Curr Med Res Opin; 2010 Oct; 26(10):2403-10. PubMed ID: 20812791
[TBL] [Abstract][Full Text] [Related]
40. Adverse events after antipsychotic discontinuation: an individual participant data meta-analysis.
Brandt L; Schneider-Thoma J; Siafis S; Efthimiou O; Bermpohl F; Loncar L; Neumann K; Hasan A; Heinz A; Leucht S; Gutwinski S
Lancet Psychiatry; 2022 Mar; 9(3):232-242. PubMed ID: 35183280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
